S'abonner

Placenta accreta spectrum: disrupted collagen architecture at a previous scar is a defining characteristic of placental adherence - 09/01/26

Doi : 10.1016/j.ajog.2025.08.094 
Lior Kashani Ligumsky, MD a, Anhyo Jeong, BS a, Guadalupe Martinez, MPH a, Haley Marks, PhD b, Sohum Shah, MD a, Jakub Staniczek, MD, PhD a, c, Caroline E. Smith, BA d, Scott A. Shainker, DO e, S. Ananth Karumanchi, MD f, Laurent A. Bentolila, PhD b, Deborah Krakow, MD a, g, h, Christina J. Megli, MD, PhD e, i, j, Yalda Afshar, MD, PhD a, k,
a Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California, Los Angeles, CA 
b Advanced Light Microscopy and Spectroscopy Laboratory, California NanoSystems Institute, UCLA, Los Angeles, CA 
c Department of Gynecology, Obstetrics and Gynecological Oncology, Medical University of Silesia, Katowice, Poland 
d Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA 
e Division of Maternal Fetal Medicine, Beth-Israel Deaconess Medical Center, Boston, MA 
f Division of Nephrology, Department of Medicine, Cedars Sinai Medical Center, Los Angeles, CA 
g Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, CA 
h Department of Orthopedic Surgery, David Geffen School of Medicine, University of California, Los Angeles, CA 
i Division of Reproductive Infectious Disease, UPMC Magee-Womens Hospital, Pittsburgh, PA 
j Magee-Womens Research Institute, Pittsburgh, PA 
k Molecular Biology Institute, University of California, Los Angeles, CA 

Corresponding author: Yalda Afshar, MD, PhD.

Abstract

Background

Placenta accreta spectrum is a severe obstetric complication associated with uterine scarring, particularly from prior cesarean births. Despite its considerable clinical sequalae, the underlying mechanisms remain unclear. Recent evidence suggests that abnormal extracellular matrix remodeling plays a pivotal role in placenta accreta spectrum pathology.

Objective

This study investigates collagen architecture and its role in placenta accreta spectrum adherence using multimodal imaging, an in vivo mouse model, and an in vitro co-culture system, aiming to identify pathophysiology of placenta accreta spectrum with implications for improved uterine repair and placenta accreta spectrum prevention.

Study Design

Human placenta accreta spectrum and nonplacenta accreta spectrum specimens were analyzed using nonlinear label-free optical imaging techniques to characterize collagen architecture at the decidual-placental interface (total n=23, placenta accreta spectrum=13). A surgical mouse model of placenta accreta spectrum was used to examine collagen organization and placental adherence patterns. Additionally, an in vitro “accreta-in-a-dish” model was developed using decidualized human uterine fibroblasts, trophoblasts, and macrophages to assess extracellular matrix remodeling, wound healing, and inflammatory interactions. Live-cell imaging and electric cell-substrate impedance sensing quantified the impact of collagen deposition and inflammation on scar resistance to electric impedance and trophoblast behavior.

Results

Disorganized fibrillar collagen deposition with disrupted border integrity was a hallmark of placenta accreta spectrum pathology, specifically at the site of adherent, compared to nonadherent placenta accreta spectrum controls in human surgical specimens. The mouse model of placenta accreta spectrum confirmed matrix disorganization at the site of abnormal placental adherence. In vitro, collagen coating enhanced wound healing, while placental-conditioned media from placenta accreta spectrum sites impaired macrophage-driven tissue repair. In vitro, trophoblasts preferentially avoided extracellular matrix-rich regions, suggesting a role for matrix composition in placental attachment and invasion. Macrophage-mediated inflammation further compromised scar resistance, indicating an inflammatory-matrix interplay that may predispose to placenta accreta spectrum.

Conclusion

These findings underscore the role of extracellular matrix dysregulation in placenta accreta spectrum, highlighting collagen architecture as a critical determinant of placental adherence. Collagen modulation and targeted inflammatory interventions could improve uterine scar healing and reduce placenta accreta spectrum incidence. Future research should focus on translating these mechanistic insights into diagnostic and therapeutic strategies for placenta accreta spectrum prevention and management.

Le texte complet de cet article est disponible en PDF.

Video


(31.06 Mo)

Le texte complet de cet article est disponible en PDF.

Plan


 Y.A. is a consultant for Mirvie and BillionToOne and has an investigator-initiated project with Natera unrelated to placenta accreta. S.A.S. received research support from the Chase Koch Foundation and serves on the Roche Pharmaceuticals Advisory Board. S.A.K. is a co-inventor of multiple preeclampsia biomarker patents that are held by Harvard Hospitals and Cedars-Sinai Medical Center. S.A.K. serves as consultants to Aggamin, Comanche Biopharma, and Thermo Fisher Scientific. The remaining authors have no disclosures to report.
  Y.A. is supported by the Burroughs Wellcome Fund Next Gen Pregnancy Fund, David Geffen School of Medicine Physician Scientist Program, K12 HD000849, and the Society for Maternal Fetal Medicine Bridge grant related to accreta. J.K. received support through the Kosciuszko Foundation , of the American Center of Polish Culture. L.B. directs the Advanced Light Microscopy/Spectroscopy Laboratory and the Leica Microsystems Center of Excellence with funding support from NIH Shared Instrumentation grant S10OD025017 and NSF Major Research Instrumentation grant CHE-0722519 .


© 2025  The Author(s). Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 233 - N° 6S

P. S645-S661.e1 - janvier 2026 Retour au numéro
Article précédent Article précédent
  • Preoperative ultrasound assessment for surgical risk management in patients with a placenta previa and a history of cesarean delivery
  • Eric Jauniaux, Albaro Jose Nieto-Calvache, Ahmed M. Hussein
| Article suivant Article suivant
  • Evaluation of histopathologic changes associated with placentation in a cesarean delivery scar
  • Simrit Nijjar, Davor Jurkovic, Ahmed M. Hussein, Carolyn JP. Jones, John D. Aplin, Eric Jauniaux

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2026 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.